| Line Item | 2026-03-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $7.1M | +51.2% |
| SG&A Expense | $9.9M | +44.1% |
| Operating Income | -$17.0M | -47.0% |
| Pre-tax Income | -$16.7M | -46.5% |
| Income Tax | $0 | — |
| Net Income | -$16.7M | -46.5% |
| EPS (Basic) | -$2.32 | +64.1% |
| Line Item | 2026-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.0M | -23.3% |
| Current Assets | $7.6M | -21.1% |
| Total Assets | $7.6M | -22.5% |
| Current Liabilities | $1.7M | -0.1% |
| Total Liabilities | $1.7M | -0.1% |
| Stockholders' Equity | $5.9M | -27.2% |
| Line Item | 2026-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.3M | -48.0% |
| Capital Expenditures | $10K | -28.6% |
| Investing Cash Flow | -$10K | +28.6% |
| Financing Cash Flow | $10.2M | +15.5% |
| Free Cash Flow | -$12.3M | -47.8% |